Printer Friendly
The Free Library
19,604,538 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Cell Bio-Systems Pursuing Government Grants for Stem Cell Research; Retains Leading Biotech Consultant to Manage Submissions Process.


SAN DIEGO San Diego (săn dēā`gō), city (1990 pop. 1,110,549), seat of San Diego co., S Calif., on San Diego Bay; inc. 1850. San Diego includes the unincorporated communities of La Jolla and Spring Valley. Coronado is across the bay.  -- Cell Bio-Systems Inc. (Pink Sheets: CBSI CBSI CUNA Brokerage Services, Inc.
CBSI Cambodian Buddhist Society, Inc. (Silver Springs, Maryland)
CBSI Certified Bridge Safety Inspector
CBSI Custom Business Solutions, Inc.
), a biotechnology company positioned to manufacture and distribute patented, disposable technologies for stem cell stem cell

In living organisms, an undifferentiated cell that can produce other cells that eventually make up specialized tissues and organs. There are two major types of stem cells, embryonic and adult.
 research, cosmetic surgery cosmetic surgery, plastic surgery for cosmetic purposes, such as the improvement of the appearance of the face by removing wrinkles or reshaping the nose.  and other living tissue procedures, announced today that it is pursuing several research grants offered by state and federal government agencies for the development of medical devices used in stem cell research.

Stem cell research is a political hot topic. From Nancy Reagan to John Kerry Editing of this page by unregistered or newly registered users is currently disabled due to vandalism. , republicans and democrats alike are acknowledging the benefits of this research (CNN.com: June 12, 2004). While the number of stem cell researchers is substantial, cutting edge instrumentation exists only within a select few companies.

"Cell Bio-Systems is positioning itself to be a major factor in this market, with government funding facilitating advancements in available instrumentation," said Marc Pilkington, Cell Bio-Systems President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. .

To further this leadership initiative, Cell Bio-Systems has retained Brian Pockett, a well-respected industry consultant, to assist with the company's grant submissions. Pockett brings an extensive background in successfully obtaining government grants for product development. His particular expertise is in obtaining funding for research and development of medical devices for the biotechnology industry. With more than 28 years of professional experience in business development and grant submissions, Pockett is expected to be a key addition in the company's development efforts for instrumentation utilized in stem cell harvesting and research.

"Cell Bio-Systems will be using its patented and proprietary technology to develop instrumentation used in stem cell research, as well as genome therapies; we believe our technologies will result in major advancements in these areas," added Pilkington. "With renewed interest in stem cell research by the federal government, numerous state governments, and related private foundations, our company plans on garnering funds to develop and expand the types of precision instrumentation necessary to support stem cell research and genome therapies."

About Cell Bio-Systems

Based in San Diego, California “San Diego” redirects here. For other uses, see San Diego (disambiguation).
San Diego is a coastal Southern California city located in the southwestern corner of the continental United States. As of 2006, the city has a population of 1,256,951.
, Cell Bio-Systems is the exclusive licensee of two patented syringe connection products that it plans to adapt as disposable devices for liposuction Liposuction Definition

Liposuction, also known as lipoplasty or suction-assisted lipectomy, is cosmetic surgery performed to remove unwanted deposits of fat from under the skin.
 and other Living Tissue Management(TM) procedures. The company is developing an affordable, disposable product Disposable products are items that are not intended by the manufacturer to be reused more than once or a few times as compared to more permanent serviceable and reusable items. Some products that have disposable versions are:
  • diapers
  • cigarette lighters
  • flatware
 line that will fill this void in the cosmetic surgery and living tissue marketplace. The company's patented, groundbreaking technology will increase patient safety and enhance procedural outcomes. Most notably, Cell Bio-Systems devices can be adapted for a variety of procedures, ranging from fat transfers to biopsies to stem cell research. The company ultimately will develop a complete living tissue management system. CBSI shareholders are encouraged to visit www.cellbiosystems.com and to register on the "Investor Relations Investor relations

The process by which the corporation communicates with its investors.
" page to receive ongoing CBSI news updates.

Legal Notice Regarding Forward-Looking Statements:

"Forward-looking statements" as defined in the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995 may be included in this news release. These statements relate to future events or our future financial performance. These statements are only predictions and may differ materially from actual future results or events. CBSI disclaims any intention or obligation to revise any forward-looking statements whether as a result of new information, future developments or otherwise. There are important risk factors that could cause actual results to differ from those contained in forward-looking statements, including, but not limited to risks associated with changes in general economic and business conditions (including in the information technology and financial information industry), actions of our competitors, the extent to which we are able to develop new services and markets for our services, the time and expense involved in such development activities, the level of demand and market acceptance of our services, and changes in our business strategies.
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jul 13, 2004
Words:592
Previous Article:Family Room Begins Editing on ``Edison''.
Next Article:CombiMatrix Announces Launch of Human Toxicology Expression Array.



Related Articles
Doctor who? Scientists are treated as objective arbiters in the cloning debate. But most have serious skin in the game.
Bio-Matrix Scientific Group Preparing to Apply for Stem Research Grant from the California Institute for Regenerative Medicine.
Should stem-cell research receive federal funding? Congress is considering relaxing the rules for funding this controversial research.
STEM CELL RESEARCH PROMISES MADE, BUT NO RESULTS.
Bio-Matrix Scientific Group Inc. Starts Final Phase of Class 10,000 Processing Laboratory Installation.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles